| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |